Myriad’s commitment to provide the most accurate testing doesn’t stop when your patient’s results are in your hands. We understand that Myriad’s results influence the clinical path you take with your patient. That’s why myVision™ is part of Myriad’s commitment to patients and their families that lasts a lifetime.
Myriad offers targeted genetic testing at no cost to selected family members in order to gather more information about a VUS result to assist in the reclassification process. When an uncertain variant result is reclassified as clinically significant, an amended report is made available to the provider.
Myriad continues to evaluate additional information as it emerges in order to classify and reclassify variants quickly and accurately.